Skip to content
Pulsewave logo — Precision in Arterial Health Monitoring

Pulsewave

Precision in Arterial Health Monitoring

Founded 2020 Pre-Seed Total: $860.00K Fashion, Health Care +1

General Information

Company Name Pulsewave
Founded Year 2020
Industries Fashion, Health Care, Medical Devices
Funding Stage Pre-Seed
Social

BounceWatch is an independent company data service, not affiliated with Pulsewave. To contact Pulsewave, visit pulsewave.ch.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Pulsewave compare?

A PDF of Pulsewave and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Pulsewave soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Pulsewave

PulseWave is a pioneering digital health care company with a focus on redefining the clinical diagnosis and long-term monitoring of arterial sclerosis. The company's innovative product, the TempleGuard, integrates a wearable biosensor seamlessly with the patient's eyeglasses, alongside cloud-based data analytics powered by proprietary algorithms. This unique combination distills data from millions of heartbeats into clinically actionable insights. Founded in 2020, PulseWave is confident that advancements in blood pressure monitoring and characterization could significantly impact how patients are clinically managed. The company recently secured a $120.00K Pre Seed Round investment on 14 September 2022 from Techstars. With its precise arterial health monitoring solutions, PulseWave is poised to make a significant impact in the healthcare industry.

Business keywords: digital health care, arterial health monitoring, wearable biosensor, cloud-based data analytics, proprietary algorithms, blood pressure monitoring, clinical diagnosis, long-term monitoring, TempleGuard, innovative product, patient management, clinical insights, cardiovascular health, health technology, medical innovation

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Pre Seed Round $120.00K 1
Techstars
14 Sep 2022
Grant Fr.480.00K 1
Innosuisse
07 Jun 2022
Pre Seed Round Fr.260.00K 1
Foundation for technological innovation
14 Jan 2022

Pulsewave Alternatives & Competitors

View All Alternatives
Pulsewave vs
Aktiia
Aktiia Switzerland

Blood Pressure Intelligence for Global Health

Series A
63 employees
AI, Hardware
Pulsewave vs
Biospectal SA
Biospectal SA Switzerland

The Optical Blood Pressure Revolution

Seed
13 employees
Hardware, Health Care
Pulsewave vs
AgaMatrix
AgaMatrix United States

We design, develop, and manufacture world-class products for diabetes care.

Debt Financing
89 employees
Health Care, Manufacturing

FAQ About Pulsewave

Precision in Arterial Health Monitoring
Pulsewave was founded in 2020.
Pulsewave operates in Fashion, Health Care and Medical Devices. Its work centres on digital health care, arterial health monitoring, wearable biosensor and cloud-based data analytics.
Pulsewave has completed 3 funding rounds, raising a total of $860.00K. The latest funding stage is Pre-Seed.
Top alternatives and competitors to Pulsewave include Aktiia, Biospectal SA, AgaMatrix, PyrAmes, CardiacSense. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Pulsewave and Aktiia are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Pulsewave, https://www.bouncewatch.com/company/pulsewave, updated 11 September 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout